Samantha Bucktrout
Company: Grey Wolf Therapeutics
Job title: Head of Research
Seminars:
ERAP1 Inhibition Reveals Novel MHC-Peptides for Targeting – Discovery, Pre- & Clinical Development Opportunities 10:15 am
We are global leaders in the therapeutic development of ERAP1 inhibitors, with clinical trials progressing in oncology ERAP1i changes the immunopeptidome on classical (HLA-A*, HLA-B*) and non classical (HLA-E, HLA-G) molecules to affect CD8 T cell and NK cell responses Pre-clinically, ERAP1i enables detection and quantification of novel tumor associated and viral peptides informing the…Read more
day: Day 2